tiprankstipranks
Trending News
More News >
Kazia Therapeutics Limited (KZIA)
NASDAQ:KZIA
US Market

Kazia Therapeutics (KZIA) Ratios

Compare
327 Followers

Kazia Therapeutics Ratios

KZIA's free cash flow for Q2 2025 was AU$1.00. For the 2025 fiscal year, KZIA's free cash flow was decreased by AU$ and operating cash flow was AU$-420.30. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 25Dec 24Dec 23
Liquidity Ratios
Current Ratio
0.21-- 0.24 1.42
Quick Ratio
0.21-- 0.24 1.93
Cash Ratio
0.19-- 0.06 0.69
Solvency Ratio
-1.00-- -0.79 -1.16
Operating Cash Flow Ratio
-0.45-- -0.37 -2.00
Short-Term Operating Cash Flow Coverage
-52.98-- -15.11 -8.44
Net Current Asset Value
AU$ -18.31M--AU$ -25.46MAU$ -5.26M
Leverage Ratios
Debt-to-Assets Ratio
<0.01-- 0.03 0.06
Debt-to-Equity Ratio
-0.04-- -0.06 0.15
Debt-to-Capital Ratio
-0.04-- -0.07 0.13
Long-Term Debt-to-Capital Ratio
0.00-- 0.00 0.00
Financial Leverage Ratio
-4.70-- -2.15 2.33
Debt Service Coverage Ratio
-163.40-- -41.79 -12.55
Interest Coverage Ratio
0.00-- 0.00 0.00
Debt to Market Cap
<0.01-- 0.08 0.56
Interest Debt Per Share
0.17-- 1.32 0.97
Net Debt to EBITDA
0.13-- 0.04 0.15
Profitability Margins
Gross Profit Margin
100.00%--100.00%100.00%
EBIT Margin
-973.57%---1240.68%-4350725.59%
EBITDA Margin
-917.33%---1159.71%-4013885.95%
Operating Profit Margin
-580.77%---1233.19%-4346661.08%
Pretax Profit Margin
-575.40%---1171.97%-3736265.23%
Net Profit Margin
-930.18%---1160.23%-3687419.82%
Continuous Operations Profit Margin
-935.62%---1160.23%-3687419.82%
Net Income Per EBT
161.66%--99.00%98.69%
EBT Per EBIT
99.08%--95.04%85.96%
Return on Assets (ROA)
-129.42%---124.06%-72.87%
Return on Equity (ROE)
335.37%--267.33%-169.83%
Return on Capital Employed (ROCE)
-1034.15%--675.74%-117.56%
Return on Invested Capital (ROIC)
-948.54%--787.50%-109.52%
Return on Tangible Assets
-672.57%---432.95%-189.22%
Earnings Yield
-289.22%---342.80%-637.93%
Efficiency Ratios
Receivables Turnover
28.18-- 17.35 0.91
Payables Turnover
0.00-- 0.00 0.00
Inventory Turnover
0.00-- 0.00 0.00
Fixed Asset Turnover
0.00-- 0.00 0.00
Asset Turnover
0.14-- 0.11 <0.01
Working Capital Turnover Ratio
-0.15-- -0.28 <0.01
Cash Conversion Cycle
12.95-- 21.03 401.17
Days of Sales Outstanding
12.95-- 21.03 401.17
Days of Inventory Outstanding
0.00-- 0.00 0.00
Days of Payables Outstanding
0.00-- 0.00 0.00
Operating Cycle
12.95-- 21.03 401.17
Cash Flow Ratios
Operating Cash Flow Per Share
-8.77-- -19.98 -8.22
Free Cash Flow Per Share
-8.77-- -19.98 -8.22
CapEx Per Share
0.00-- 0.00 0.00
Free Cash Flow to Operating Cash Flow
1.00-- 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
0.00-- 0.00 0.00
Capital Expenditure Coverage Ratio
0.00-- 0.00 0.00
Operating Cash Flow Coverage Ratio
-52.98-- -15.11 -8.44
Operating Cash Flow to Sales Ratio
-2.99-- -4.15 -27.31K
Free Cash Flow Yield
-48.83%---122.65%-47.24%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-0.35-- -0.29 -0.16
Price-to-Sales (P/S) Ratio
6.12-- 3.38 5.78K
Price-to-Book (P/B) Ratio
-2.10-- -0.78 0.27
Price-to-Free Cash Flow (P/FCF) Ratio
-2.05-- -0.82 -0.21
Price-to-Operating Cash Flow Ratio
-1.07-- -0.82 -0.21
Price-to-Earnings Growth (PEG) Ratio
-0.01-- 0.00 <0.01
Price-to-Fair Value
-2.10-- -0.78 0.27
Enterprise Value Multiple
-0.54-- -0.25 0.01
Enterprise Value
12.35M-- 6.79M 28.64M
EV to EBITDA
-0.54-- -0.25 -1.29
EV to Sales
4.95-- 2.94 51.60K
EV to Free Cash Flow
-1.66-- -0.71 -1.89
EV to Operating Cash Flow
-1.66-- -0.71 -1.89
Tangible Book Value Per Share
-21.49-- -53.00 -2.83
Shareholders’ Equity Per Share
-4.48-- -20.89 6.54
Tax and Other Ratios
Effective Tax Rate
>-0.01-- 0.01 -0.01
Revenue Per Share
2.93-- 4.81 <0.01
Net Income Per Share
-27.26-- -55.83 -11.11
Tax Burden
1.62-- 0.99 0.99
Interest Burden
0.59-- 0.94 0.86
Research & Development to Revenue
6.10-- 7.53 28.04K
SG&A to Revenue
4.64-- 5.88 15.46K
Stock-Based Compensation to Revenue
0.13-- 0.23 2.09K
Income Quality
0.32-- 0.36 0.74
Currency in AUD